BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shi C, Lamba N, Zheng LJ, Cote D, Regestein QR, Liu CM, Tran Q, Routh S, Smith TR, Mekary RA, Broekman MLD. Depression and survival of glioma patients: A systematic review and meta-analysis. Clin Neurol Neurosurg 2018;172:8-19. [PMID: 29957299 DOI: 10.1016/j.clineuro.2018.06.016] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 4.6] [Reference Citation Analysis]
Number Citing Articles
1 Dragioti E, Radua J, Solmi M, Gosling CJ, Oliver D, Lascialfari F, Ahmed M, Cortese S, Estradé A, Arrondo G, Gouva M, Fornaro M, Batiridou A, Dimou K, Tsartsalis D, Carvalho AF, Shin JI, Berk M, Stringhini S, Correll CU, Fusar-Poli P. Impact of mental disorders on clinical outcomes of physical diseases: an umbrella review assessing population attributable fraction and generalized impact fraction. World Psychiatry 2023;22:86-104. [PMID: 36640414 DOI: 10.1002/wps.21068] [Reference Citation Analysis]
2 Wu X, Wang D, Wang D. Risk factors, prognostic potency, and longitudinal variation of anxiety and depression in postoperative glioma patients. Front Surg 2023;9. [DOI: 10.3389/fsurg.2022.1069709] [Reference Citation Analysis]
3 Staub-Bartelt F, Steinmann J, Radtke O, Hänggi D, Sabel M, Rapp M. Impact of COVID-19 Epidemic on Psycho-Oncological Distress in Neuro-Oncological Patients. Curr Oncol 2022;30:358-69. [PMID: 36661678 DOI: 10.3390/curroncol30010029] [Reference Citation Analysis]
4 Ge LL, Xing MY, Zhang HB, Li QF, Wang ZC. Role of nerves in neurofibromatosis type 1-related nervous system tumors. Cell Oncol (Dordr) 2022. [PMID: 36327093 DOI: 10.1007/s13402-022-00723-3] [Reference Citation Analysis]
5 van Coevorden-van Loon EMP, Heijenbrok-Kal MH, Horemans HLD, Boere R, de Bat RAKM, Vincent AJPE, van den Bent MJ, Ribbers GM. The relationship between mental fatigue, cognitive functioning, and employment status in patients with low-grade glioma: a cross-sectional single-center study. Disabil Rehabil 2022;44:7413-9. [PMID: 34694184 DOI: 10.1080/09638288.2021.1991013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
6 Hsu EJ, Thomas J, Timmerman RD, Wardak Z, Dan TD, Patel TR, Sanford NN, Vo DT. Socioeconomic and demographic determinants of radiation treatment and outcomes in glioblastoma patients. Front Neurol 2022;13. [DOI: 10.3389/fneur.2022.1024138] [Reference Citation Analysis]
7 Pieczyńska A, Pilarska A, Adamska K, Zasadzka E, Hojan K. Psychological Characteristics Associated with Post-Treatment Physical Status and Quality of Life in Patients with Brain Tumor Undergoing Radiotherapy. J Pers Med 2022;12. [PMID: 36579602 DOI: 10.3390/jpm12111880] [Reference Citation Analysis]
8 Young JS, Al-adli N, Sibih YE, Scotford KL, Casey M, James S, Berger MS. Recognizing the psychological impact of a glioma diagnosis on mental and behavioral health: a systematic review of what neurosurgeons need to know. Journal of Neurosurgery 2022. [DOI: 10.3171/2022.9.jns221139] [Reference Citation Analysis]
9 Ribeiro M, Benadjaoud MA, Moisy L, Jacob J, Feuvret L, Balcerac A, Bernier M, Psimaras D, Hoang-xuan K, Noel G, Jouniaux-delbez N, Ricard D. Symptoms of Depression and Anxiety in Adults with High-Grade Glioma: A Literature Review and Findings in a Group of Patients before Chemoradiotherapy and One Year Later. Cancers 2022;14:5192. [DOI: 10.3390/cancers14215192] [Reference Citation Analysis]
10 Meza-garcía CF, Reynaga-ornelas L, Rodríguez-medina RM, Dávalos-pérez A, Pérez-reyes SP. Panorama epidemiológico de las neoplasias encefálicas con tratamiento quirúrgico en un hospital de tercer nivel en Guanajuato, México. SANUS 2022;7:e246. [DOI: 10.36789/revsanus.vi1.246] [Reference Citation Analysis]
11 Hu Y, Deng F, Zhang L, Hu K, Liu S, Zhong S, Yang J, Zeng X, Peng X. Depression and Quality of Life in Patients with Gliomas: A Narrative Review. JCM 2022;11:4811. [DOI: 10.3390/jcm11164811] [Reference Citation Analysis]
12 Rabin EE, Kim M, Mozny A, Cardoza K, Bell AC, Zhai L, Bommi P, Lauing KL, King AL, Armstrong TS, Walunas TL, Fang D, Roy I, Peipert JD, Sieg E, Mi X, Amidei C, Lukas RV, Wainwright DA. A systematic review of pharmacologic treatment efficacy for depression in older patients with cancer. Brain, Behavior, & Immunity - Health 2022;21:100449. [DOI: 10.1016/j.bbih.2022.100449] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Staub-bartelt F, Radtke O, Hänggi D, Sabel M, Rapp M. Impact of Anticipated Awake Surgery on Psychooncological Distress in Brain Tumor Patients. Front Oncol 2022;11:795247. [DOI: 10.3389/fonc.2021.795247] [Reference Citation Analysis]
14 van der Meer PB, Koekkoek JAF, Dirven L, Taphoorn MJB. Quality of Life and Brain Cancer. Handbook of Quality of Life in Cancer 2022. [DOI: 10.1007/978-3-030-84702-9_23] [Reference Citation Analysis]
15 Tel H, Gürler H. İki Farklı Fiziksel Hastalık Tanısı Olan Bireylerde Anksiyete, Depresyon ve Stresle Başa Çıkma Düzeylerinin Belirlenmesi. Hacettepe Üniversitesi Hemşirelik Fakültesi Dergisi 2021. [DOI: 10.31125/hunhemsire.1050350] [Reference Citation Analysis]
16 Bazi Alahri M, Arshadizadeh R, Raeisi M, Khatami M, Sadat Sajadi M, Kamal Abdelbasset W, Akhmadeev R, Iravani S. Theranostic applications of metal–organic frameworks (MOFs)-based materials in brain disorders: Recent advances and challenges. Inorganic Chemistry Communications 2021;134:108997. [DOI: 10.1016/j.inoche.2021.108997] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
17 Oh TK, Song IA, Park HY, Jeon YT. Depression and mortality after craniotomy for brain tumor removal: A Nationwide cohort study in South Korea. J Affect Disord 2021;295:291-7. [PMID: 34482061 DOI: 10.1016/j.jad.2021.08.058] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Loughan AR, Husain M, Ravyts SG, Willis KD, Braun SE, Brechbiel JK, Aslanzadeh FJ, Rodin G, Svikis DS, Thacker L. Death anxiety in patients with primary brain tumor: Measurement, prevalence, and determinants. Pall Supp Care 2021;19:672-80. [DOI: 10.1017/s1478951521000808] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Merrell RT, Simon KC, Martinez N, Vazquez RM, Hadsell B, Epshteyn A, Wilk G, Frigerio R, Maraganore DM. Standardizing Care of Neuro-oncology Patients Using a Customized Electronic Medical Record Toolkit. Mayo Clin Proc Innov Qual Outcomes 2021;5:625-34. [PMID: 34195554 DOI: 10.1016/j.mayocpiqo.2021.04.001] [Reference Citation Analysis]
20 John F, Michelhaugh SK, Barger GR, Mittal S, Juhász C. Depression and tryptophan metabolism in patients with primary brain tumors: Clinical and molecular imaging correlates. Brain Imaging Behav 2021;15:974-85. [PMID: 32767048 DOI: 10.1007/s11682-020-00305-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Zhao X. Reminiscence therapy-based care program for reducing anxiety and depression in glioma survivors: A randomized controlled trial. Medicine (Baltimore) 2021;100:e23056. [PMID: 33592815 DOI: 10.1097/MD.0000000000023056] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
22 Balakrishna P, George S, Hatoum H, Mukherjee S. Serotonin Pathway in Cancer. Int J Mol Sci 2021;22:1268. [PMID: 33525332 DOI: 10.3390/ijms22031268] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
23 Dinapoli L, Chiesa S, Dinapoli N, Gatta R, Beghella Bartoli F, Bracci S, Mazzarella C, Sanfilippo MZ, Sabatino G, Gaudino S, Della Pepa GM, Frascino V, Valentini V, Balducci M. Personalised support of brain tumour patients during radiotherapy based on psychological profile and quality of life. Support Care Cancer 2021;29:4555-63. [PMID: 33479794 DOI: 10.1007/s00520-021-06000-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
24 Hao A, Huang J, Xu X. Anxiety and depression in glioma patients: prevalence, risk factors, and their correlation with survival. Ir J Med Sci 2021;190:1155-64. [PMID: 33140294 DOI: 10.1007/s11845-020-02374-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
25 Senf B, Grabowski K, Spielmann N, Fettel J. Quality of life and distress assessed with self and external assessment screening tools in patients with hematologic malignancies attending treatment in an acute hospital. Qual Life Res 2020;29:3375-85. [PMID: 32815114 DOI: 10.1007/s11136-020-02602-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Srivastava S, Bhatia MS, Gaur A, Singh G. Psychiatric and cognitive correlates of quality of life among persons with primary brain tumors. Ind Psychiatry J 2019;28:141-7. [PMID: 31879461 DOI: 10.4103/ipj.ipj_72_19] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
27 Otto-Meyer S, DeFaccio R, Dussold C, Ladomersky E, Zhai L, Lauing KL, Bollu LR, Amidei C, Lukas RV, Scholtens DM, Wainwright DA. A retrospective survival analysis of Glioblastoma patients treated with selective serotonin reuptake inhibitors. Brain Behav Immun Health 2020;2:100025. [PMID: 32190845 DOI: 10.1016/j.bbih.2019.100025] [Cited by in Crossref: 11] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
28 Liu B, Liu J, Liu K, Huang H, Li Y, Hu X, Wang K, Cao H, Cheng Q. A prognostic signature of five pseudogenes for predicting lower-grade gliomas. Biomedicine & Pharmacotherapy 2019;117:109116. [DOI: 10.1016/j.biopha.2019.109116] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 7.0] [Reference Citation Analysis]
29 Verhaak E, Schimmel WCM, Sitskoorn MM, Bakker M, Hanssens PEJ, Gehring K. Multidimensional assessment of fatigue in patients with brain metastases before and after Gamma Knife radiosurgery. J Neurooncol 2019;144:377-84. [PMID: 31350667 DOI: 10.1007/s11060-019-03240-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
30 Otto-Meyer S, Lumibao J, Kim E, Ladomersky E, Zhai L, Lauing KL, Scholtens DM, Penedo F, Amidei C, Lukas RV, Wainwright DA. The interplay among psychological distress, the immune system, and brain tumor patient outcomes. Curr Opin Behav Sci 2019;28:44-50. [PMID: 31049368 DOI: 10.1016/j.cobeha.2019.01.009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]